Authors: Meynard, JL Guiguet, M Rachline, A Boukli, N Bollens, D Gentil, C Frottier, J Morand-Joubert, L

Citation: Jl. Meynard et al., Factors predicting response to antiretroviral regimens with a protease inhibitor in HIV-infected subjects, PRESSE MED, 30(1), 2001, pp. 5-10

Authors: Lefrere, JJ Roudot-Thoraval, F Morand-Joubert, L Brossard, Y Parnet-Mathieu, F Mariotti, M Agis, F Rouet, G Lerable, J Lefevre, G Girot, R Loiseau, P

Citation: Jj. Lefrere et al., Prevalence of GB virus type C hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: evidence of sexual and parenteral transmission, TRANSFUSION, 39(1), 1999, pp. 83-94

Authors: Lefrere, JJ Mariotti, H Morand-Joubert, L Thauvin, M Roudot-Thoraval, F

Citation: Jj. Lefrere et al., Plasma human immunodeficiency virus RNA below 40 copies/mL is rare in untreated persons even in the first years of infection, J INFEC DIS, 180(2), 1999, pp. 526-529

Authors: Lefrere, JJ Roudot-Thoraval, F Morand-Joubert, L Petit, JC Lerable, J Thauvin, M Mariotti, M

Citation: Jj. Lefrere et al., Carriage of GB virus C hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons, J INFEC DIS, 179(4), 1999, pp. 783-789

Authors: Lefrere, JJ Guiramand, S Mariotti, M Aumont, P Girot, R Morand-Joubert, L

Citation: Jj. Lefrere et al., Full or partial seroreversion in patients infected by hepatitis C virus may occur in three circumstances: spontaneously, induced by alpha interferon therapy, in conjunction with HIV infection, HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD, 1997, pp. 95-100